Coherus BioSciences Announces FDA Acceptance of 351(k) Biologics License Application for CHS-1701 Biotech Investing
Provectus Biopharmaceuticals Files Registration Statement for Rights Offering to Existing Stockholders Biotech Investing
Advanced Accelerator Applications Announces Pricing of $150 Million Public Offering of American Depositary Shares Biotech Investing
PX’Therapeutics and Relief Therapeutics Announce Strategic Collaboration Agreement for the Recombinant Production of Atexakin Alfa Biotech Investing
Organovo Introduces 3D Bioprinted Human Liver as Leading Therapeutic Tissue in Preclinical Development Emerging Technology Investing
